Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis

被引：0

作者：

Babayeva, Sabina ^{[1
]}

Dyatlov, Arteni ^{[1
]}

Pallavi, Ranjita ^{[1
]}

Fanucchi, Michael ^{[1
]}

Puccio, Carmelo ^{[1
]}

Lafaro, Rocco ^{[1
]}

Shakil, Fouzia ^{[1
]}

Fallon, John T. ^{[1
]}

Zhong, Minghao ^{[1
]}

机构：

[1] New York Med Coll, Valhalla, NY 10595 USA

来源：

MODERN PATHOLOGY | 2016年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

1851

引用

页码：467A / 467A

页数：1

共 50 条

[21] Effects of Neoadjuvant Therapy on Programmed Cell Death Ligand 1 (PD-L1) Expression and Immune Microenviroment in Non-Small Cell Lung Cancer (NSCLC) [J].

Tomaszewski, Kristen ;

Huynh, Tiffany ;

Kem, Marina ;

Mino-Kenudson, Mari .

MODERN PATHOLOGY, 2018, 31 :753-754

[22] Effects of Neoadjuvant Therapy on Programmed Cell Death Ligand 1 (PD-L1) Expression and Immune Microenviroment in Non-Small Cell Lung Cancer (NSCLC) [J].

Tomaszewski, Kristen ;

Huynh, Tiffany ;

Kem, Marina ;

Mino-Kenudson, Mari .

LABORATORY INVESTIGATION, 2018, 98 :753-754

[23] Immunotherapy efficacy of programmed cell death 1 (PD-1) versus programmed death ligand-1 (PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients: A systematic review and meta-analysis. [J].

Yang, Danrong ;

Cui, Longgang ;

Zhang, Yuzi ;

Zhao, Zhengyi ;

Bai, Yuezong .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[24] Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC). [J].

Gainor, Justin F. ;

Sequist, Lecia V. ;

Shaw, Alice Tsang ;

Azzoli, Christopher G. ;

Piotrowska, Zofia ;

Huynh, Tiffany ;

Fulton, Linnea ;

Schultz, Katherine ;

Hata, Aaron N. ;

Engelman, Jeffrey A. ;

Mino-Kenudson, Mari .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[25] Programmed cell death ligand-1 (PD-L1) as a biomarker for non-small cell lung cancer (NSCLC) treatment-are we barking up the wrong tree? [J].

Dempke, Wolfram C. M. ;

Fenchel, Klaus ;

Dale, Stephen P. .

TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 :S275-S279

[26] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma [J].

Driver, Brandon ;

Miller, Ross A. ;

Deavers, Michael ;

Tacha, David ;

Bernicker, Eric ;

Cagle, Philip T. .

LABORATORY INVESTIGATION, 2017, 97 :475A-475A

[27] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis [J].

Liang, Jiaqi ;

Li, Ming ;

Sui, Qihai ;

Hu, Zhengyang ;

Bian, Yunyi ;

Huang, Yiwei ;

Zhan, Cheng ;

Jiang, Wei ;

Wang, Qun ;

Tan, Lijie .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) :1302-+

[28] Programmed death-ligand 1 (PD-L1) expression and testing experience in a cohort of advanced non-small cell lung cancer (NSCLC) patients [J].

Decatris, M. ;

Hayes, M. ;

Reed, N. ;

Bhalla, V. ;

Thomas, J. ;

Gaikwad, K. ;

Birchall, K. ;

Phillips, A. ;

Ryan, P. ;

Du Rand, I. ;

Taniere, P. .

LUNG CANCER, 2018, 115 :S42-S42

[29] Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer [J].

Capizzi, Elisa ;

Ricci, Costantino ;

Giunchi, Francesca ;

Zagnoni, Stefano ;

Ceccarelli, Claudio ;

Gomez, Begona Urrios Alvarez ;

Casolari, Laura ;

Gelsomino, Francesco ;

Trisolini, Rocco ;

Fiorentino, Michelangelo ;

Ardizzoni, Andrea .

LUNG CANCER, 2018, 126 :9-14

[30] Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer [J].

Pan, Yunjian ;

Zheng, Difan ;

Li, Yuan ;

Cai, Xu ;

Zheng, Zongli ;

Jin, Yan ;

Hu, Haichuan ;

Cheng, Chao ;

Shen, Lei ;

Wang, Jian ;

Ji, Hongbin ;

Sun, Yihua ;

Zhou, Xiaoyan ;

Chen, Haiquan .

JOURNAL OF THORACIC DISEASE, 2017, 9 (08) :2579-2586

← 1 2 3 4 5 →